Drug
Desvenlafaxine clinical trials
Also written Pristiq and DVS-233.
Keep track of what changes. Save the desvenlafaxine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2006 (7)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 7 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 33 · Other 18
Wyeth is now a wholly owned subsidiary of Pfizer (20) · Pfizer (10) · Tongji Hospital (2) · Luye Pharma Group Ltd. (2) · David Steffens (1) · Mochida Pharmaceutical Company, Ltd. (1) · Unity Health Toronto (1) · START Clinic for Mood and Anxiety Disorders (1)
Often tested with
Tested in the same studies.
Venlafaxine (3) · Toludesvenlafaxine (2) · Sertraline (1) · Bupropion (1) · Escitalopram (1) · Pregabalin (1)
Studies
Open first, then newest update. How each study uses desvenlafaxine is read from its arms, and is right about nine times in ten.
Testing it · 51
- The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With FibromyalgiaRecruitingNot applicableBeijing Tiantan HospitalNCT07171320Written as Pregabalin with desvenlafaxine
- Predictors of Cognitive Outcomes in Geriatric DepressionActive, not recruitingPhase 4David SteffensNCT05273996Written as Sertraline, bupropion, desvenlafaxine
- Desvenlafaxine for Preventive Treatment of Frequent MigrainesActive, not recruitingNot applicableTongji HospitalNCT07385755Written as Desvenlafaxine
- Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type HeadacheActive, not recruitingNot applicableTongji HospitalNCT07359248Written as Desvenlafaxine
- A Study of MD-120 in Patients With DepressionCompletedPhase 3Mochida Pharmaceutical Company, Ltd.NCT04345471Written as Desvenlafaxine 100 mg
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00406640Written as Desvenlafaxine succinate sustained-release (DVS SR)
- Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral NeuropathyTerminatedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT01050218Written as Desvenlafaxine Succinate Sustained-Release (DVS SR)
- Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine TreatmentCompletedPhase 4Unity Health TorontoNCT02859103Written as Desvenlafaxine
- Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other ComorbitiesCompletedPhase 4START Clinic for Mood and Anxiety DisordersNCT01975480Written as Desvenlafaxine
- Desvenlafaxine in Opioid-Dependent PatientsCompletedPhase 4Centre hospitalier de l'Université de Montréal (CHUM)NCT02200406Written as Desvenlafaxine
- Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking TamoxifenTerminatedPhase 4Seoul National University HospitalNCT02819921Written as Desvenlafaxine succinate 100mg
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedPhase 3PfizerNCT01372150Written as desvenlafaxine succinate sustained release
- A Study of LY03005 vs PristiqCompletedPhase 1Luye Pharma Group Ltd.NCT03733574Written as Pristiq
- Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®CompletedPhase 1Luye Pharma Group Ltd.NCT03357796Written as Pristiq
- Desvenlafaxine vs. Placebo Treatment of Chronic DepressionCompletedPhase 4New York State Psychiatric InstituteNCT01537068Written as Desvenlafaxine
- 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety DisorderCompletedPhase 4The Medical Research NetworkNCT01316302Written as Pristiq
- Neurocognition and Work Productivity in Major Depressive Disorder (MDD)CompletedNot applicableUniversity of British ColumbiaNCT01468610Written as desvenlafaxine
- Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular DepressionStatus unknownPhase 4Hotel-Dieu Grace HealthcareNCT01974934Written as Desvenlafaxine Succinate
- Functional Outcome in Postpartum Depression in Women Treated With DesvenlafaxineCompletedPhase 3BC Women's Hospital & Health CentreNCT01527786Written as Desvenlafaxine
- Prediction of Antidepressant Treatment Response Using Machine Learning Classification AnalysisStatus unknownPhase 4University of CalgaryNCT02330679Written as Desvenlafaxine
See all 51 studies that test desvenlafaxine →
Given in every arm · 3 — desvenlafaxine is usual care beside what is tested
- A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderCompletedPhase 3BiogenNCT04476030Written as Desvenlafaxine
- Omega 3 FA Supplements as Augmentation in the Treatment of DepressionTerminatedPhase 2/3UConn HealthNCT01803711Written as Desvenlafaxine
- Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of MidazolamCompletedPhase 4PfizerNCT00952653Written as Desvenlafaxine Succinate Sustained Release
As the comparator · 3 — what is tested is compared with desvenlafaxine
- Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From DepressionCompletedPhase 4H. Lundbeck A/SNCT04448431Written as Desvenlafaxine
- Pilot BA Study of New LY03005 vs PristiqCompletedPhase 1Luye Pharma Group Ltd.NCT02988024Written as Pristiq
- Safety, Tolerability and Pharmacokinetics Study of LY03005CompletedPhase 1Luye Pharma Group Ltd.NCT02055300Written as Pristiq
Codes
What other systems call desvenlafaxine · ClinicalTrials.gg INT006594
- MeSH (NLM) D000069468Desvenlafaxine SuccinateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) NG99554ANWDESVENLAFAXINEConfirmed FDA, NLM, Wikidata
- RxNorm 734064Confirmed FDA, Wikidata
- Wikidata Q2419445desvenlafaxineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61703DesvenlafaxineOne source FDA
- DrugBank DB06700One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069468 | Desvenlafaxine Succinate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | NG99554ANW | DESVENLAFAXINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 734064 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2419445 | desvenlafaxine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61703 | Desvenlafaxine | One source FDA |
| DrugBank | DB06700 | — | One source Wikidata |
Also registered as desvenlafaxine succinate (UNII ZB22ENF0XR · RxNorm 683693).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.